Off goes AKYA. The stock jumped down today. Lets find out what's happening:

Akoya Biosciences, Inc. (AKYA) is trading -7% lower at $13.22 today. The stock fell today, a sign of weakness as there was a flurry of buying in the biotech sector today and Akoya fell behind it's peers. The embattled biotech company has been trying to seek new sources of growth in an environment of increased operating costs. Investors appear to be bearish about their chances today.

Akoya Biosciences, Inc. has been trading between a 52-week high of $21.21 and a 52-week low of $8.02. The stock has a market cap of $497 Million.

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX® and Phenoptics™ platforms, to serve the diverse needs of researchers across discovery, translational and clinical research.